About Abselion
Biologic quantification, made simple & reliable.
Abselion develops practical measurement tools that make reliable results fast and accessible. The company combines robust engineering, purpose-built assays, and intuitive software to help teams move from sample to answer with confidence. Abselion is backed by private investment, including M Ventures, and supported by competitive innovation programmes, including Innovate UK and the National Research Council (NRC). Its flagship platform Amperia™ is powered by Redox Electrochemical Detection (RED) technology, delivering consistent quantification across antibodies, AAVs, and tagged proteins—even in crude samples.
Sectors
- antibodies
- kits
- in vitro reagents
- molecular
- proteins